A Phase Ib/II, Open-Label, Multicenter, Randomized Umbrella Study Evaluating The Efficacy And Safety Of Multiple Immunotherapy-Based Treatment Combinations In Patients With Metastatic Colorectal Cancer (Morpheus-CRC)
Colon | Rectum
What is the purpose of this trial?
A phase Ib/II, open-label, multicenter, randomized study designed to assess the safety, tolerability, pharmacokinetics and preliminary anti-tumor activity of immunotherapy-based treatment combinations in patients with metastatic colorectal cancer (mCRC) who experienced disease progression during or following two lines of treatment.
Eligible patients will be assigned to one of several treatment arms.
- Trial withF. Hoffman-La Roche Ltd
- Start Date10/02/2018
- End Date03/31/2020
- Last Updated12/02/2018
- Study HIC#2000023122